Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 09/05/24
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with BuntanetapGlobeNewsWire • 07/24/24
Annovis Bio's stock rockets 119% after reporting positive data in Parkinson's disease trialMarket Watch • 07/02/24
Annovis Bio's Buntanetap Found Safe and Effective in High-Risk Alzheimer's PatientsGlobeNewsWire • 06/11/24
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a BetZacks Investment Research • 05/28/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of InvestorsBusiness Wire • 05/17/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of InvestorsBusiness Wire • 05/16/24
The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of InvestorsBusiness Wire • 05/16/24
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsGlobeNewsWire • 05/13/24
Annovis, Anavex, And Cassava Sciences: Trying To Box Oneself Out Of The Alzheimer's BoxSeeking Alpha • 05/10/24
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's DiseaseGlobeNewsWire • 05/09/24
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer's DiseaseGlobeNewsWire • 04/29/24
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to TradeZacks Investment Research • 04/24/24
Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?Zacks Investment Research • 04/08/24
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 04/02/24
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in HumansGlobeNewsWire • 04/01/24
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a BetZacks Investment Research • 03/21/24